GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Verici Dx PLC (OTCPK:VRCDF) » Definitions » ROC (Joel Greenblatt) %

VRCDF (Verici Dx) ROC (Joel Greenblatt) % : -210.65% (As of Jun. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Verici Dx ROC (Joel Greenblatt) %?

Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits). He defines ROC (Joel Greenblatt) % as EBIT divided by the total of Property, Plant and Equipment and net working capital. Verici Dx's annualized ROC (Joel Greenblatt) % for the quarter that ended in Jun. 2024 was -210.65%.

The historical rank and industry rank for Verici Dx's ROC (Joel Greenblatt) % or its related term are showing as below:

VRCDF' s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: -1338.25   Med: -835.43   Max: -343.12
Current: -343.12

During the past 4 years, Verici Dx's highest ROC (Joel Greenblatt) % was -343.12%. The lowest was -1338.25%. And the median was -835.43%.

VRCDF's ROC (Joel Greenblatt) % is ranked worse than
80.8% of 224 companies
in the Medical Diagnostics & Research industry
Industry Median: -7.81 vs VRCDF: -343.12

Verici Dx's 5-Year average Growth Rate of ROC (Joel Greenblatt) % was 0.00% per year.


Verici Dx ROC (Joel Greenblatt) % Historical Data

The historical data trend for Verici Dx's ROC (Joel Greenblatt) % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Verici Dx ROC (Joel Greenblatt) % Chart

Verici Dx Annual Data
Trend Dec20 Dec21 Dec22 Dec23
ROC (Joel Greenblatt) %
- -1,332.64 -815.59 -516.16

Verici Dx Semi-Annual Data
Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
ROC (Joel Greenblatt) % Get a 7-Day Free Trial -1,043.32 -715.06 -576.06 -458.99 -210.65

Competitive Comparison of Verici Dx's ROC (Joel Greenblatt) %

For the Diagnostics & Research subindustry, Verici Dx's ROC (Joel Greenblatt) %, along with its competitors' market caps and ROC (Joel Greenblatt) % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Verici Dx's ROC (Joel Greenblatt) % Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Verici Dx's ROC (Joel Greenblatt) % distribution charts can be found below:

* The bar in red indicates where Verici Dx's ROC (Joel Greenblatt) % falls into.


;
;

Verici Dx ROC (Joel Greenblatt) % Calculation

Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits) . He defines Return on Capital as follows:

ROC (Joel Greenblatt) %=EBIT/Average of (Net fixed Assets + Net Working Capital)

EBIT stands for Earnings Before Interest and Taxes.

Fixed Assets are also known as non-current assets. They include the Property, Plant and Equipment that the firm needs in its operation.

GuruFocus calculates net working capital as: (Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Deferred Revenue + Other Current Liabilities). We're trying to account for OPERATING assets and liabilities (part of daily business) when calculating working capital. Cash and marketable securities are considered NON-OPERATING assets and are not included in calculation. We will also back out all interest bearing debt, short term debt and the portion of long term debt that is due in the current period from the current liabilities. This debt will be considered when computing cost of capital and it would be inappropriate to count it twice.

Working Capital(Q: Dec. 2023 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(1.013 + 0 + 0.244) - (0.523 + 0 + 2.822)
=-2.088

Working Capital(Q: Jun. 2024 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(1.5 + 0 + 0.386) - (0.668 + 0 + 1.119)
=0.099000000000001

When net working capital is negative, 0 is used.

So ROC (Joel Greenblatt) % of Verici Dx for the quarter that ended in Jun. 2024 can be restated as:

ROC (Joel Greenblatt) %(Q: Jun. 2024 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Dec. 2023  Q: Jun. 2024
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=-2.67/( ( (1.363 + max(-2.088, 0)) + (1.073 + max(0.099000000000001, 0)) )/ 2 )
=-2.67/( ( 1.363 + 1.172 )/ 2 )
=-2.67/1.2675
=-210.65 %

Note: The EBIT data used here is two times the semi-annual (Jun. 2024) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Verici Dx  (OTCPK:VRCDF) ROC (Joel Greenblatt) % Explanation

The way Joel Greenblatt defines Return on Capital is a more accurate measure of how efficiently the company generates returns onthe capital actually invested in the business. EBIT is used instead of net income because the tax and interest payment may be affected by factors other than the core business operation. Intangible assets are not included in the calculation because they don't need to be replaced.

Joel Greenblatt uses his definition of Return on Capital and Earnings Yield (Joel Greenblatt) % to rank companies.


Verici Dx ROC (Joel Greenblatt) % Related Terms

Thank you for viewing the detailed overview of Verici Dx's ROC (Joel Greenblatt) % provided by GuruFocus.com. Please click on the following links to see related term pages.


Verici Dx Business Description

Traded in Other Exchanges
Address
19 Stanwell Road, Avon House, Penarth, Cardiff, GBR, CF64 2EZ
Verici Dx PLC is an immuno-diagnostics development company. The company is focused on developing diagnostics technologies that will help understand the outcomes of an organ transplant surgery. There are two products for clinical validation and commercialization: Clarava, which is a pre-transplant prognosis for the risk of early acute rejection; and Tuteva, a post-transplant diagnostic focused upon acute cellular rejection including sub-clinical rejection not being diagnosed through the current standard of care of rising serum creatine levels. The business of the Group comprises a single activity, which of the development of prognostic and diagnostic tests for kidney transplant patients.

Verici Dx Headlines

No Headlines